<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>ZFLEX- acetaminophen and phenyltoloxamine citrate tablet </strong><br>Huckaby Pharmaceuticals, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>NDC 35501-023-01 <br>ZFLEX <br>ACETAMINOPHEN <br>AND <br>PHENYLTOLOXAMINE <br>TABLETS, USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<p class="First">Each Tablet Contains:</p>
<table width="30%">
<col align="left" valign="middle" width="80%">
<col align="right" valign="middle" width="20%">
<tbody class="Headless"><tr class="Botrule First Last Toprule">
<td align="left">Acetaminophen</td>
<td align="right">500 mg</td>
</tr></tbody>
</table>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4b04b21b-ee68-4c59-91ad-57c3d84e2b09&amp;name=zflex-01.jpg"></div>
<table width="30%">
<col align="left" valign="middle" width="80%">
<col align="right" valign="middle" width="20%">
<tbody class="Headless"><tr class="Botrule First Last Toprule">
<td align="left">Phenyltoloxamine Citrate</td>
<td align="right">55 mg</td>
</tr></tbody>
</table>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4b04b21b-ee68-4c59-91ad-57c3d84e2b09&amp;name=zflex-02.jpg"></div>
<p>Acetaminophen, 4'-hydroxyacetanilide, a slightly bitter, white odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.</p>
<p>Phenyltoloxamine citrate is an antihistamine having the chemical name <span class="Italics">N</span>, <span class="Italics">N</span>-dimethyl-2-(α-phenyl-<span class="Italics">o</span>-tolyloxy) ethylamine dihydrogen citrate.</p>
<p>Inactive ingredients: Each tablet contains povidone, microcrystalline cellulose, sodium starch glycolate and magnesium stearate.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The analgesic action of acetaminophen involves peripheral influences, but the specific mechanism is as yet undetermined. Antipyretic activity is mediated through hypothalamic heat regulating centers. Acetaminophen inhibits prostaglandin synthetase. Therapeutic doses of acetaminophen have negligible effects on the cardiovascular or respiratory systems; however, toxic doses may cause <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">circulatory failure</span> and rapid, <span class="product-label-link" type="condition" conceptid="4302536" conceptname="Shallow breathing">shallow breathing</span>. </p>
<div class="Section" data-sectionCode="43682-4">
<a name="section-3.1"></a><p></p>
<h2>Pharmacokinetics</h2>
<p class="First">The behavior of the individual components is described below.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-3.1.1"></a><p></p>
<h3>Acetaminophen</h3>
<p class="First">Acetaminophen is rapidly absorbed from the gastrointestinal tract and is distributed throughout most body tissues. The plasma half-life is 1.25 to 3 hours, but may be increased by <span class="product-label-link" type="condition" conceptid="4352876" conceptname="Liver damage">liver damage</span> and following overdosage. Elimination of acetaminophen is principally by liver metabolism (conjugation) and subsequent renal excretion of metabolites. Approximately 85% of an oral dose appears in the urine within 24 hours of administration, most as the glucuronide conjugate, with small amounts of other conjugates and unchanged drug.</p>
<p>See <span class="Bold"><a href="#OD">OVERDOSAGE</a></span> for toxicity information.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-3.1.2"></a><p></p>
<h3>Phenyltoloxamine Citrate</h3>
<p class="First">Phenyltoloxamine is an H<span class="Sub">1</span> blocking agent which interferes with the action of histamine primarily in capillaries surrounding mucous tissues and sensory nerves of the nasal and adjacent areas. It has the ability to interfere with certain areas of acetylcholine-inhibiting secretions in the nose, mouth and pharynx. It commonly causes <span class="product-label-link" type="condition" conceptid="4171908" conceptname="Semicoma">CNS depression</span>.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">For the temporary relief of minor <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">aches</span> and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pains</span> associated with <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>, <span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">backache</span>, muscular <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">aches</span>, the menstrual and premenstrual periods, <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">colds</span>, the flu, <span class="product-label-link" type="condition" conceptid="4099176" conceptname="Toothache">toothaches</span>, as well as for minor <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> from <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span>, and to reduce <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">This product should not be administered to patients who have previously exhibited <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to acetaminophen or phenyltoloxamine citrate.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<div class="Section" data-sectionCode="34075-2">
<a name="section-6.1"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">In patients with severe hepatic or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>, effects of therapy should be monitored with serial liver and/or renal function tests.</p>
</div>
<div class="Section" data-sectionCode="34074-5">
<a name="section-6.2"></a><p></p>
<h2>Drug/Laboratory Test Interactions</h2>
<p class="First">Acetaminophen may produce false-positive test results for urinary 5-hydroxyindoleacetic acid. The sedative effects of phenyltoloxamine citrate are additive to the CNS depressant effects of alcohol, hypnotics, sedatives and tranquilizers.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No adequate studies have been conducted in animals to determine whether phenyltoloxamine citrate or acetaminophen has a potential for carcinogenesis, mutagenesis, or impairment of fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-6.4.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="section-6.4.1.1"></a><p></p>
<h4>Pregnancy Category C</h4>
<p class="First">There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-6.5"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Acetaminophen is excreted in breast milk in small amounts, but the significance of its effects on nursing infants is not known. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from phenyltoloxamine citrate and acetaminophen, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-6.6"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in the pediatric population have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<p class="First">Dermatological: <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>.</p>
<p>The following adverse drug events may be borne in mind as potential effects of acetaminophen: <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="OD"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Following an acute overdosage, toxicity may result from phenyltoloxamine citrate or acetaminophen. </p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.1"></a><p></p>
<h2>Acetaminophen</h2>
<p class="First">In acetaminophen overdosage: dose-dependent, potentially fatal <span class="product-label-link" type="condition" conceptid="4337543" conceptname="Hepatic necrosis">hepatic necrosis</span> is the most serious adverse effect. <span class="product-label-link" type="condition" conceptid="444044" conceptname="Acute tubular necrosis">Renal tubular necrosis</span>, <span class="product-label-link" type="condition" conceptid="380688" conceptname="Hypoglycemic coma">hypoglycemic coma</span>, and <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span> may also occur.</p>
<p>Early symptoms following a potentially hepatotoxic <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> may include: <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">diaphoresis</span> and <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">general malaise</span>. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours post-ingestion.</p>
<p>In adults, hepatic toxicity has rarely been reported with <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">acute overdoses</span> of less than 10 grams, or fatalities with less than 15 grams.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.2"></a><p></p>
<h2>Treatment</h2>
<p class="First">A single or multiple <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> with phenyltoloxamine citrate or acetaminophen is a potentially lethal <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, and consultation with a regional poison control center is recommended. Immediate treatment includes support of cardiorespiratory function and measures to reduce drug absorption. <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span> should be induced mechanically, or with syrup of ipecac, if the patient is alert (adequate pharyngeal and laryngeal reflexes).</p>
<p>If the dose of acetaminophen may have exceeded 140 mg/kg, acetylcysteine should be administered as early as possible. Serum acetaminophen levels should be obtained, since levels four or more hours following ingestion help predict acetaminophen toxicity. Do not await acetaminophen assay results before initiating treatment. Hepatic enzymes should be obtained initially, and repeated at 24-hour intervals. <span class="product-label-link" type="condition" conceptid="432882" conceptname="Methemoglobinemia">Methemoglobinemia</span> over 30% should be treated with methylene blue by slow intravenous administration. The toxic dose for adults for acetaminophen is 10 g. </p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1>Dosage</h1>
<p class="First">Adults 12 years and over - ½ or 1 tablet every 4 hours.<br>Maximum daily dose - 5 tablets.<br>Children 6 to under 12 years - ½ tablet every 4 hours.<br>Maximum daily dose - 2½ tablets<br>Children under 6 years of age: consult a physician. </p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-10"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Do not take this product for <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> for more than 10 days (adults) or 5 days (children), and do not take for <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> for more than 3 days unless directed by a physician. If <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> or <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> persists, if new symptoms occur, or if <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> or <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> is present, consult a physician immediately because these could be signs of a serious condition. Do not give this product to children under 12 years of age for the <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> of <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span> unless directed by a physician. May cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>; alcohol, sedatives and tranquilizers may increase the <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> effect. Avoid alcoholic beverages while taking this product. Do not take this product if you are taking sedatives or tranquilizers without first consulting your physician. Use caution when driving a motor vehicle or operating machinery.</p>
<p><span class="Bold">Keep this and all drugs out of the reach of children.</span> In case of accidental <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, seek professional assistance or contact a Poison Control Center immediately. Prompt medical attention is critical, for adults as well as for children, even if you do not notice any signs or symptoms. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-11"></a><p></p>
<p class="First"><span class="Bold">STORE AT ROOM TEMPERATURE</span> 15°-30°C (59°-86°F), <span class="Bold">AVOID EXCESSIVE HEAT</span>.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-12"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">NDC# 35501-023-01 Bottles of 100 count tablets; and samples NDC# 35501-023-02 containing 4 tablets. A red capsule shaped tablet with a score on both sides. Both sides with "ZFLEX" on the left side of the score and a blank space on the right side of the score. If tablet is broken at the score, one side will display "ZFLEX" and the other side will be blank.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-13"></a><p></p>
<p class="First"><span class="Bold">Rx only</span></p>
<p><span class="Bold">Manufactured for:<br>Huckaby Pharmaceuticals, Inc.<br>Crestwood, KY 40014</span></p>
<p>MG #27909</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label</h1>
<p class="First"><span class="Bold">NDC 35501-023-01</span></p>
<p><span class="Bold">ZFLEX™</span></p>
<p><span class="Bold">100 Tablets</span></p>
<p><span class="Bold">Rx Only</span></p>
<p><span class="Bold">Distributed by:<br><span class="Italics">H</span>UCKABY<br>Pharmaceuticals, Inc</span><br>Crestwood, KY 40014<br>Tel. 502-241-1570</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4b04b21b-ee68-4c59-91ad-57c3d84e2b09&amp;name=zflex-03.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ZFLEX 		
					</strong><br><span class="contentTableReg">acetaminophen and phenyltoloxamine citrate tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:35501-023</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Acetaminophen</strong> (Acetaminophen) </td>
<td class="formItem">Acetaminophen</td>
<td class="formItem">500 mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>Phenyltoloxamine Citrate</strong> (Phenyltoloxamine) </td>
<td class="formItem">Phenyltoloxamine Citrate</td>
<td class="formItem">55 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>povidone</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>cellulose, microcrystalline</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>magnesium stearate</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">RED</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">RECTANGLE</td>
<td class="formLabel">Size</td>
<td class="formItem">19mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">ZFLEX</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:35501-023-01</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">04/12/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Huckaby Pharmaceuticals, Inc.
							(624844507)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 4/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>eeae604c-98fa-40dc-b205-9aa8184c9b10</div>
<div>Set id: 4b04b21b-ee68-4c59-91ad-57c3d84e2b09</div>
<div>Version: 1</div>
<div>Effective Time: 20100412</div>
</div>
</div> <div class="DistributorName">Huckaby Pharmaceuticals, Inc.</div></p>
</body></html>
